Department of Planning and BudgetAn official website of the Commonwealth of Virginia Here's how you knowAn official websiteHere's how you know
| Action Summary | The amendments adopt four new substantive provisions in Medication (11 VAC 10-180-10 et seq.). The provisions are (i) the possessing or administering Erythropietin or any analogous substance is prohibited, (ii) prohibiting the use of "shockwave therapy" devices on racehorses ten days prior to a race, (iii) treating racehorses three hours or less prior to post time, and (iv) restricting the levels of carbon dioxide concentrations in post-race testing. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: 2.2-4002 (B) (23) |
| RIS Project | No project yet assigned to this action |
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Stage ID | Stage Type | Status |
|---|---|---|
| 2229 | Final | Stage complete. This regulation became effective on 03/31/2003. |
| Name / Title: | Kimberly Mackey / Regulatory Coordinator |
| Address: |
Virginia Racing Commission 10700 Horsemens Road New Kent, VA 23124 |
| Email Address: | kimberly.mackey@vrc.virginia.gov |
| Phone: | (804)966-7406 FAX: ()- TDD: ()- |
